# Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination

> **NCT06155019** · — · COMPLETED · sponsor: **Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida** · enrollment: 109 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06155019
- **Lead sponsor:** Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-08
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-09-15
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155019, "Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06155019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*